BridgeMD
Tests treatment safety and results for Adhesive Capsulitis of Shoulder
Official title Investigation of the Effectiveness of Exercise and Anti-Fibrotic Approaches in Frozen Shoulder
ClinicalTrials.gov ID: NCT07513350
What this study is testing
What is Losartan?
Losartan is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for adhesive capsulitis of shoulder.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this clinical study is to investigate the efficacy of losartan as an antifibrotic approach in addition to a physiotherapy program in patients diagnosed with frozen shoulder. The effects of losartan use on pain intensity, shoulder joint range of motion, functional status, and pain catastrophizing level will be evaluated and compared with the outcomes of patients participating in a physiotherapy program alone.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years or older diagnosed with frozen shoulder (adhesive capsulitis)
- Having less than 50% of range of motion (ROM) in at least one of the following shoulder movements compared to the unaffected side: external rotation...
- Having more than 25% loss of ROM in at least two movement planes compared to the unaffected shoulder
- Patients in stage II or III of frozen shoulder
You likely can't join if
- Women who are pregnant, breastfeeding, or planning pregnancy during the study
- Patients in stage I of frozen shoulder
- Patients diagnosed with inflammatory or other types of arthritis due to autoimmune diseases affecting the shoulder
- Patients with rotator cuff pathology and/or glenohumeral arthritis
- Patients with a history of prior shoulder infection
- Patients with hypotension
See the full eligibility criteria
- Adults aged 18 years or older diagnosed with frozen shoulder (adhesive capsulitis)
- Having less than 50% of range of motion (ROM) in at least one of the following shoulder movements compared to the unaffected side: external rotation, abduction, flexion, or internal rotation
- Having more than 25% loss of ROM in at least two movement planes compared to the unaffected shoulder
- Patients in stage II or III of frozen shoulder
- Women who are pregnant, breastfeeding, or planning pregnancy during the study
- Patients in stage I of frozen shoulder
- Patients diagnosed with inflammatory or other types of arthritis due to autoimmune diseases affecting the shoulder
- Patients with rotator cuff pathology and/or glenohumeral arthritis
- Patients with a history of prior shoulder infection
- Patients with hypotension
- Patients who have undergone previous upper extremity surgery or plan to undergo upper extremity surgery during the study period
- Patients with allergy to losartan or its active/inactive components
- Patients taking medications known to have adverse interactions with losartan
- Patients who, in the investigator's opinion, have any medical condition, laboratory abnormality, or history that could pose risk, contraindicate participation, affect the conduct, objectives, or evaluation of the study...
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.